LIXTE BIOTECHNOLOGY HOLDINGS, INC. (22) | Business Operations (2)
- Sales Agreements (1)
- Services Agreements (1)
- Sales Agreement dated as of September 20, 2021 between Lixte Biotechnology Holdings, Inc. and WestPark Capital, Inc (Filed With SEC on September 20, 2021)
- Master Service Agreement with Foundation of Angelman Syndrome Therapeutics FAST (Filed With SEC on August 18, 2020)